Acologix, Inc. AC-200 Demonstrates Positive Effect on Bone in Preclinical Model of Chronic Kidney Disease Data Presented at the 41st Annual Meeting of the American Society of Nephrology
11/7/2008 9:21:34 AM
More...
|
Acologix, Inc. Presents Preclinical Data on Cartilage Regeneration by AC-100 at the 30th ASBMR Annual Meeting
9/12/2008 7:57:59 AM
More...
|
Acologix, Inc. Presents Preclinical Data on Cartilage Regeneration by AC-100 at the OARSI 2007 World Congress on Osteoarthritis
12/7/2007 7:12:03 AM
More...
|
Dawn McGuire, M.D. Joins Acologix, Inc. as Chief Medical Officer
11/2/2007 7:21:23 AM
More...
|
Acologix, Inc. Licenses Novel Technology For Treatment Of Interstitial Cystitis From University Of Maryland, Baltimore
9/7/2006 1:52:36 PM
More...
|
Acologix, Inc. Files For $115 Million IPO
8/17/2006 8:44:47 AM
More...
|
Acologix, Inc. Announces Results Of AC-100 Initial Feasibility Study For Treatment Of Periodontal Disease
7/25/2006 10:45:18 AM
More...
|
Acologix, Inc.' AC-100 (Dentonin(R)) Phase II Data On Dentin Formation In Humans Presented At The Annual Meeting Of The International Association For Dental Research
6/30/2006 10:42:41 AM
More...
|
Acologix, Inc. And Toray Industries, Inc. (TRYIY) To Collaborate In Development Of Drug Candidate For Renal Disease
6/26/2006 5:52:00 PM
More...
|
Acologix, Inc. And Toray Industries, Inc. (TRYIY) Announce Partnership On AC-200 (Phosphatonin)
6/20/2006 11:09:31 AM
More...
|
|